Last reviewed · How we verify
Spinal anesthesia for lumbar surgery: ropivacaine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Spinal anesthesia for lumbar surgery: ropivacaine (Spinal anesthesia for lumbar surgery: ropivacaine) — Fraser Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Spinal anesthesia for lumbar surgery: ropivacaine TARGET | Spinal anesthesia for lumbar surgery: ropivacaine | Fraser Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Spinal anesthesia for lumbar surgery: ropivacaine CI watch — RSS
- Spinal anesthesia for lumbar surgery: ropivacaine CI watch — Atom
- Spinal anesthesia for lumbar surgery: ropivacaine CI watch — JSON
- Spinal anesthesia for lumbar surgery: ropivacaine alone — RSS
Cite this brief
Drug Landscape (2026). Spinal anesthesia for lumbar surgery: ropivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/spinal-anesthesia-for-lumbar-surgery-ropivacaine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab